Cardiff Oncology
Migdalia Gonzalez is a skilled professional in the field of biomedical research and management, currently serving as a Senior Research Associate at Cardiff Oncology since August 2021. Prior to this role, Migdalia was the Services and Lab Manager at BioSpyder Technologies from November 2016 to August 2021. Migdalia's early experience includes working as an Undergraduate Research Assistant at the University of Arizona from December 2010 to August 2014. Migdalia holds a Bachelor of Science in Cell/Cellular and Molecular Biology and a Bachelor of Arts in French Language and Literature, both obtained from the University of Arizona.
Cardiff Oncology
Cardiff Oncology is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need. Our goal is to overcome resistance, improve response to treatment and increase overall survival. We are developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.